Clinical Trials in the USA / NCT06624215
Active, not recruiting
Observational
Retrospective Acute Care Appendectomy Study
NCT06624215 · tracked via the Priya Life Science USA tracker
Condition(s) studied
Acute Appendicitis
Investigational drug(s) / intervention(s)
Appendectomy
Appendectomy: Robotic-assisted or laparoscopic appendectomy for acute appendicitis.
Study summary
The purpose of this retrospective study is to compare perioperative data for subjects who have undergone an emergent or urgent robotic-assisted or laparoscopic appendectomy for acute appendicitis.
Eligibility
Inclusion Criteria:
* Subject is 22 years of age or older at time of procedure
* Subject has undergone robotic-assisted or laparoscopic emergent or urgent appendectomy for acute appendicitis between 2018 and 30 days prior to IRB approval
Exclusion Criteria:
* Subject with appendiceal neoplasms
* Subject who underwent a single-port appendectomy
* Subject who was pregnant or breastfeeding at the time of the procedure
Primary outcome measure(s)
- Operative time — Intraoperative
- Procedure time — Intraoperative
- Conversion — Intraoperative
- Adverse events — Intraoperative and postoperative out to 30 days from procedure date
- Mortality rate through 30 days — Intraoperative and postoperative out to 30 days from procedure date
All cause - Unplanned procedure-related readmission rate through 30 days — Discharge through 30 days
- Concomitant procedures — Intraoperative
- Estimated blood loss — Intraoperative
- Severity of appendicitis — Preoperative
- Unplanned procedure-related reoperation rate through 30 days — Postoperative through 30 days
- Length of stay — Start of procedure to discharge from the hospital (check-out time), up to approximately one week
Total number of days the subject stayed in the hospital after the index procedure prior to being discharged. - Discharge disposition — Discharge from the hospital (check-out time), up to approximately one week.
Where the subject was discharged to when released from the hospital - Blood Transfusion — Intraoperative and discharge from the hospital (check-out time), up to approximately one week.
Any occurrence of blood transfusion either at the time of the procedure or at any point during the post-procedure hospitalization until the participant is discharged.
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| The Ohio State University | Columbus | Ohio | |
| Legacy Emanuel Hospital & Health Center | Portland | Oregon | |
| Christus Santa Rosa Health Care Corporation | New Braunfels | Texas |
More Intuitive Surgical trials in the USA
Real World Registry for Use of the Ion Endoluminal System
Active, not recruiting
Open Nipple Sparing Mastectomy (NSM)
Active, not recruiting
Clinical Investigation of the da Vinci Surgical System
Active, not recruiting
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
Active, not recruiting
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06624215 on ClinicalTrials.gov ↗ ← All trials in the USA